ArticleBMC endocrine disorders2025

Effect and safety of pemafibrate for patients with type 2 diabetes mellitus and hypertriglyceridemia: a retrospective analysis of clinical data.

Aki Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.